Abstract

Abstract not requested. This is an NCI Diversity Supplement to Dr. Cullen Taniguchi's Grant# 1R01CA227517-01A1, titled, Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer.

Public Health Relevance

Project Narrative is not requested. This is an NCI Diversity Supplement to Dr. Cullen Taniguchi's Grant# 1R01CA227517-01A1, titled, Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA227517-02S1
Application #
10134891
Study Section
Program Officer
Prasanna, Pat G
Project Start
2019-04-01
Project End
2024-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost

  Institution

Name
University of Texas MD Anderson Cancer Center
Department
Radiation-Diagnostic/Oncology
Type
Hospitals
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030